RJFSA
IOVA icon

Raymond James Financial Services Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.68M Buy
179,021
+19,921
+13% +$189K ﹤0.01% 1843
2024
Q2 		$1.28M Buy
159,100
+22,346
+16% +$239K ﹤0.01% 1934
2024
Q1 		$2.03M Buy
136,754
+6,467
+5% +$75.3K ﹤0.01% 1636
2023
Q4 		$1.06M Buy
130,287
+42,692
+49% +$223K ﹤0.01% 1948
2023
Q3 		$399K Buy
87,595
+68,436
+357% +$447K ﹤0.01% 2460
2023
Q2 		$135K Buy
+19,159
New +$137K ﹤0.01% 3016
2021
Q3 		– Sell
-8,888
Closed -$231K – 3356
2021
Q2 		$231K Buy
+8,888
New +$231K ﹤0.01% 2909
2021
Q1 		– Sell
-6,924
Closed -$321K – 3233
2020
Q4 		$321K Sell
6,924
-900
-12% -$35.7K ﹤0.01% 2422
2020
Q3 		$258K Sell
7,824
-244
-3% -$7.48K ﹤0.01% 2372
2020
Q2 		$221K Sell
8,068
-440
-5% -$14.5K ﹤0.01% 2431
2020
Q1 		$255K Sell
8,508
-775
-8% -$20.5K ﹤0.01% 1940
2019
Q4 		$257K Sell
9,283
-4,100
-31% -$93.3K ﹤0.01% 2413
2019
Q3 		$244K Sell
13,383
-2,175
-14% -$48.1K ﹤0.01% 2364
2019
Q2 		$381K Buy
+15,558
New +$234K ﹤0.01% 2100

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Raymond James Financial Services Advisors's IOVA Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Iovance Biotherapeutics (IOVA) stake by 13% in Q3 2024, buying an estimated $189K and bringing the position to 179,021 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Raymond James Financial Services Advisors first reported a position in IOVA in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.03M in Q1 2024. 286 funds tracked by Wall St. Rank hold IOVA as of Q3 2024.

  • Raymond James Financial Services Advisors held 179,021 shares of Iovance Biotherapeutics worth $1.68M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 19,921 Iovance Biotherapeutics shares in Q3 2024, an estimated $189K.
  • Iovance Biotherapeutics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1843 holding.
  • Raymond James Financial Services Advisors first reported a position in Iovance Biotherapeutics in Q2 2019 and has held it in 14 quarters since.
  • Raymond James Financial Services Advisors's Iovance Biotherapeutics position peaked at $2.03M in Q1 2024.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.